Mast cells disrupt the duodenal mucosal integrity: Implications for the mechanisms of barrier dysfunction in functional dyspepsia

References

• Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev. 1997;77(4):1033–1079.
   PubMed Web of Science ®Google Scholar
• Wouters MM, Vicario M, Santos J. The role of mast cells in functional GI disorders. Gut. 2016;65(1):155–168.
   PubMed Web of Science ®Google Scholar
• Stone KD, Prussin C, Metcalfe DD. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol. 2010;125(2):S73–S80.
   PubMed Web of Science ®Google Scholar
• Atiakshin D, Buchwalow I, Samoilova V, et al. Tryptase as a polyfunctional component of mast cells. Histochem Cell Biol. 2018;149(5):461–477.
   PubMed Web of Science ®Google Scholar
• Vanheel H, Vicario M, Vanuytsel T, et al. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut. 2014;63(2):262–271.
   PubMed Web of Science ®Google Scholar
• Wauters L, Burns G, Ceulemans M, et al. Duodenal inflammation: an emerging target for functional dyspepsia? Expert Opin Ther Targets. 2020;24(6):511–523.
   PubMed Web of Science ®Google Scholar
• Wang X, Li X, Ge W, et al. Quantitative evaluation of duodenal eosinophils and mast cells in adult patients with functional dyspepsia. Ann Diagn Pathol. 2015;19(2):50–56.
   PubMed Web of Science ®Google Scholar
• Maher S, Brayden DJ, Feighery L, et al. Cracking the junction: update on the progress of gastrointestinal absorption enhancement in the delivery of poorly absorbed drugs. Crit Rev Ther Drug Carrier Syst. 2008;25(2):117–168.
   PubMed Web of Science ®Google Scholar
• Schneeberger EE, Lynch RD. The tight junction: a multifunctional complex. Am J Physiol Cell Physiol. 2004;286(6):C1213–1228.
   PubMed Web of Science ®Google Scholar
• Günzel D, Yu AS. Claudins and the modulation of tight junction permeability. Physiol Rev. 2013;93(2):525–569.
   PubMed Web of Science ®Google Scholar
• Taki M, Oshima T, Li M, et al. Duodenal low-grade inflammation and expression of tight junction proteins in functional dyspepsia. Neurogastroenterol Motil. 2019;31(10):e13576.
   PubMed Web of Science ®Google Scholar
• Du L, Shen J, Kim JJ, et al. Impact of gluten consumption in patients with functional dyspepsia: a case-control study. J Gastroenterol Hepatol. 2018;33(1):128–133.
   PubMed Web of Science ®Google Scholar
• Enck P, Azpiroz F, Boeckxstaens G, et al. Functional dyspepsia. Nat Rev Dis Primers. 2017;3:17081.
   PubMed Web of Science ®Google Scholar
• Ford AC, Mahadeva S, Carbone MF, et al. Functional dyspepsia. Lancet. 2020;396(10263):1689–1702.
   PubMed Web of Science ®Google Scholar
• Stanghellini V, Chan FK, Hasler WL, et al. Gastroduodenal disorders. Gastroenterology. 2016;150(6):1380–1392.
   PubMed Web of Science ®Google Scholar
• Burri E, Barba E, Huaman JW, et al. Mechanisms of postprandial abdominal bloating and distension in functional dyspepsia. Gut. 2014;63(3):395–400.
   PubMed Web of Science ®Google Scholar
• Barbara G, Feinle-Bisset C, Ghoshal UC, et al. The intestinal microenvironment and functional gastrointestinal disorders. Gastroenterology. 2016;150(6):1305–1318.e8.
   Web of Science ®Google Scholar
• Wauters L, Talley NJ, Walker MM, et al. Novel concepts in the pathophysiology and treatment of functional dyspepsia. Gut. 2020;69(3):591–600.
   PubMed Web of Science ®Google Scholar
• Talley NJ. What causes functional gastrointestinal disorders? A proposed disease model. Am J Gastroenterol. 2020;115(1):41–48.
   PubMed Web of Science ®Google Scholar
• Wilcz-Villega EM, McClean S, O'Sullivan MA. Mast cell tryptase reduces junctional adhesion molecule-A (JAM-A) expression in intestinal epithelial cells: implications for the mechanisms of barrier dysfunction in irritable bowel syndrome. Am J Gastroenterol. 2013;108(7):1140–1151.
   PubMed Web of Science ®Google Scholar
• Yamashita S, Yokoyama Y, Hashimoto T, et al. A novel in vitro co-culture model comprised of caco-2/RBL-2H3 cells to evaluate anti-allergic effects of food factors through the intestine. J Immunol Methods. 2016;435:1–6.
   PubMed Web of Science ®Google Scholar
• Sambuy Y, De Angelis I, Ranaldi G, et al. The caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on caco-2 cell functional characteristics. Cell Biol Toxicol. 2005;21(1):1–26.
   PubMed Web of Science ®Google Scholar
• Engle MJ, Goetz GS, Alpers DH. Caco-2 cells express a combination of colonocyte and enterocyte phenotypes. J. Cell. Physiol. 1998;174(3):362–369.
   PubMed Web of Science ®Google Scholar
• Wu L, Oshima T, Tomita T, et al. Serotonin disrupts esophageal mucosal integrity: an investigation using a stratified squamous epithelial model. J Gastroenterol. 2016;51(11):1040–1049.
   PubMed Web of Science ®Google Scholar
• Wu L, Oshima T, Li M, et al. Filaggrin and tight junction proteins are crucial for IL-13-mediated esophageal barrier dysfunction. Am J Physiol Gastrointest Liver Physiol. 2018;315(3):G341–g350.
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101–1108.
   PubMed Web of Science ®Google Scholar
• Ji R, Wang P, Kou GJ, et al. Impaired gastric mucosal integrity identified by confocal endomicroscopy in Helicobacter pylori-negative functional dyspepsia. Neurogastroenterol Motil. 2020;32(1):e13719.
   PubMed Web of Science ®Google Scholar
• Vanheel H, Vicario M, Boesmans W, et al. Activation of eosinophils and mast cells in functional dyspepsia: an ultrastructural evaluation. Sci Rep. 2018;8(1):5383.
   PubMed Web of Science ®Google Scholar
• Komori K, Ihara E, Minoda Y, et al. The altered mucosal barrier function in the duodenum plays a role in the pathogenesis of functional dyspepsia. Dig Dis Sci. 2019;64(11):3228–3239.
   PubMed Web of Science ®Google Scholar
• Puthanmadhom Narayanan S, O’Brien DR, Sharma M, et al. Duodenal mucosal barrier in functional dyspepsia. Clin Gastroenterol Hepatol. 2022;20(5):1019–1028.e3.
   PubMed Web of Science ®Google Scholar
• Nojkov B, Zhou SY, Dolan RD, et al. Evidence of duodenal epithelial barrier impairment and increased pyroptosis in patients with functional dyspepsia on confocal laser endomicroscopy and "ex vivo" mucosa analysis. Am J Gastroenterol. 2020;115(11):1891–1901.
   PubMed Web of Science ®Google Scholar
• Barmeyer C, Erko I, Awad K, et al. Epithelial barrier dysfunction in lymphocytic colitis through cytokine-dependent internalization of claudin-5 and -8. J Gastroenterol. 2017;52(10):1090–1100.
   PubMed Web of Science ®Google Scholar
• Barmeyer C, Fromm M, Schulzke JD. Active and passive involvement of claudins in the pathophysiology of intestinal inflammatory diseases. Pflugers Arch. 2017;469(1):15–26.
   PubMed Web of Science ®Google Scholar
• Čužić S, Antolić M, Ognjenović A, et al. Claudins: beyond tight junctions in human IBD and murine models. Front Pharmacol. 2021;12:682614.
   PubMed Web of Science ®Google Scholar
• Rowart P, Wu J, Caplan MJ, et al. Implications of AMPK in the formation of epithelial tight junctions. Int J Mol Sci. 2018;19:2040.
   PubMed Web of Science ®Google Scholar
• Miller HR, Pemberton AD. Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunology. 2002;105(4):375–390.
   PubMed Web of Science ®Google Scholar
• Lee JW, Park JH, Park DI, et al. Subjects with diarrhea-predominant IBS have increased rectal permeability responsive to tryptase. Dig Dis Sci. 2010;55(10):2922–2928.
   PubMed Web of Science ®Google Scholar
• Jacob C, Yang PC, Darmoul D, et al. Mast cell tryptase controls paracellular permeability of the intestine. Role of protease-activated receptor 2 and beta-arrestins. J Biol Chem. 2005;280(36):31936–31948.
   PubMed Web of Science ®Google Scholar
• Ossovskaya VS, Bunnett NW. Protease-activated receptors: contribution to physiology and disease. Physiol Rev. 2004;84(2):579–621.
   PubMed Web of Science ®Google Scholar
• DeFea KA, Zalevsky J, Thoma MS, et al. Beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol. 2000;148(6):1267–1281.
   PubMed Web of Science ®Google Scholar
• Fyfe M, Bergström M, Aspengren S, et al. PAR-2 activation in intestinal epithelial cells potentiates interleukin-1beta-induced chemokine secretion via MAP kinase signaling pathways. Cytokine. 2005;31(5):358–367.
   PubMed Web of Science ®Google Scholar
• Al-Sadi R, Guo S, Ye D, et al. TNF-α modulation of intestinal epithelial tight junction barrier is regulated by ERK1/2 activation of elk-1. Am J Pathol. 2013;183(6):1871–1884.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Wang YW, Ni PF, et al. Effect of tryptase on mouse brain microvascular endothelial cells via protease-activated receptor 2. J Neuroinflamm. 2018;15(1):248.
   PubMed Web of Science ®Google Scholar
• Ocak U, Eser Ocak P, Huang L, et al. Inhibition of mast cell tryptase attenuates neuroinflammation via PAR-2/p38/NFκB pathway following asphyxial cardiac arrest in rats. J Neuroinflamm. 2020;17(1):144.
   PubMed Web of Science ®Google Scholar
• Song J, He Z, Yang M, et al. HepaticIschemia/reperfusion injuryinvolves functional tryptase/PAR-2 signaling in liver sinusoidal endothelial cell population. Int Immunopharmacol. 2021;100:108052.
   PubMed Web of Science ®Google Scholar
• Weiß F, Holthaus D, Kraft M, et al. Human duodenal organoid-derived monolayers serve as a suitable barrier model for duodenal tissue. Ann N Y Acad Sci. 2022;1515(1):155–167.
   PubMed Web of Science ®Google Scholar